Annual Statements Open main menu

EMAGIN CORP - Quarter Report: 2008 September (Form 10-Q)

form10q.htm

 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
 

Washington, D.C. 20549


Form 10-Q


 
(Mark One)
R
QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the quarterly period ended September 30, 2008
 
or
   
£
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the transition period from           to

Commission file number 001-15751

eMAGIN CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
56-1764501
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)

10500 NE 8th Street, Suite 1400, Bellevue, Washington 98004
(Address of principal executive offices)

(425) 749-3600
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:  None

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $.001 Par Value Per Share


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes R     No £

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.  See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.   (Check one):

Large accelerated filer £               Accelerated filer £             Non-accelerated filer £         Smaller reporting company R

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act) Yes £    No R

The number of shares of common stock outstanding as of October 31, 2008 was 15,018,839.
 
1

 
eMagin Corporation
Form 10-Q
For the Quarter ended September 30, 2008

Table of Contents
     
   
Page
PART I   FINANCIAL INFORMATION
 
Item 1
Condensed Consolidated Financial Statements
 
     
 
Condensed Consolidated Balance Sheets as of September 30, 2008 (unaudited) and December 31, 2007
3
     
 
Condensed Consolidated Statements of Operations for the Three and Nine Months ended September 30, 2008 and 2007 (unaudited)
4
     
 
Condensed Consolidated Statements of Changes in Capital Deficit for the Nine Months ended September 30, 2008 (unaudited)
5
     
 
Condensed Consolidated Statements of Cash Flows for the Nine Months ended September 30, 2008 and 2007 (unaudited)
6
     
 
Notes to Condensed Consolidated Financial Statements (unaudited)
7
     
Item 2
Management’s Discussion and Analysis of Financial Condition and Results of Operations
17
     
Item 3
Quantitative and Qualitative Disclosures About Market Risk                                                                                                                   
21
     
Item 4T
Controls and Procedures                                                                                                                   
21
   
PART II OTHER INFORMATION
 
Item 1
Legal Proceedings                                                                                                                   
23
     
Item 1A
Risk Factors                                                                                                                   
23
     
Item 2
Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                   
23
     
Item 3
Defaults Upon Senior Securities                                                                                                                   
23
     
Item 4
Submission of Matters to a Vote of Security Holders                                                                                                                   
23
     
Item 5
Other Information                                                                                                                   
23
     
Item 6
Exhibits                                                                                                                   
23
   
SIGNATURES
 
   
CERTIFICATIONS
 
 
 
 
2

 

ITEM 1.  Condensed Consolidated Financial Statements

eMAGIN CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
 
   
September 30,
   
 December 31,
 
   
2008
(unaudited)
   
 2007
(as restated, see Note 10)
 
             
ASSETS
           
             
Current assets:
           
Cash and cash equivalents
  $ 1,272     $ 713  
Investments – held to maturity
    94       94  
Accounts receivable, net
    4,002       2,383  
Inventory
    1,978       1,815  
Prepaid expenses and other current assets
    711       850  
Total current assets
    8,057       5,855  
Equipment, furniture and leasehold improvements, net
    348       292  
Intangible assets, net
    48       51  
Other assets
    231       232  
Deferred financing costs, net
    507       218  
Total assets
  $ 9,191     $ 6,648  
                 
LIABILITIES AND CAPITAL DEFICIT
               
                 
Current liabilities:
               
Accounts payable
  $ 746     $ 620  
Accrued compensation
    886       891  
Other accrued expenses
    737       729  
Advance payments
          35  
Deferred revenue
    125       179  
Current portion of  debt
    8,375       7,089  
Other current liabilities
    743       1,020  
Total current liabilities
    11,612       10,563  
                 
Long-term debt
    38       60  
    Total liabilities
    11,650       10,623  
                 
Commitments and contingencies
               
                 
Redeemable common stock:  525,500 shares redeemable as of September 30, 2008
and 162,500 shares redeemable as of December 31, 2007
    429       195  
                 
Capital deficit:
               
Preferred stock, $.001 par value: authorized 10,000,000 shares; no shares issued and outstanding
           
       Series A Senior Secured Convertible Preferred stock, stated value $1,000 per share, $.001 par value:  3,198 shares designated and none issued
           
Common stock, $.001 par value: authorized 200,000,000 shares, issued and outstanding, 14,496,339 shares as of September 30, 2008 and 12,458,400 shares as of December 31, 2007, net of redeemable common stock
    14       12  
Additional paid-in capital
    198,846       195,131  
Accumulated deficit
    (201,748 )     (199,313 )
Total capital deficit
    (2,888 )     (4,170 )
Total liabilities and capital deficit
  $ 9,191     $ 6,648  
 
See notes to Condensed Consolidated Financial Statements.

 
3

 

eMAGIN CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(unaudited)

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
   
2008
   
2007
   
2008
   
2007
 
Revenue:
                       
                         
Product revenue
  $ 4,181     $ 4,318     $ 11,139     $ 11,985  
Contract revenue
    1,004       753       2,330       927  
                                 
Total revenue, net
    5,185       5,071       13,469       12,912  
                                 
Cost of goods sold
    2,801       3,059       8,110       9,120  
                                 
Gross profit
    2,384       2,012       5,359       3,792  
                                 
Operating expenses:
                               
                                 
Research and development
    306       564       1,614       2,304  
Selling, general and administrative
    1,293       1,434       4,797       5,198  
Total operating expenses
    1,599       1,998       6,411       7,502  
                                 
Income (loss) from operations
    785       14       (1,052 )     (3,710 )
                                 
Other income (expense):
                               
                                 
  Interest expense
    (508 )     (592 )     (1,677 )     (2,766 )
  Loss on extinguishment of debt
          (10,749 )           (10,749 )
  Loss on warrant derivative liability
          (1,496 )           (853 )
  Other income, net
    84       172       294       762  
    Total other expense
    (424 )     (12,665 )     (1,383 )     (13,606 )
                                 
Net income (loss)
  $ 361     $ (12,651 )   $ (2,435 )   $ (17,316 )
                                 
                                 
Income (loss) per share, basic
  $ 0.02     $ (1.06 )   $ (0.18 )   $ (1.53 )
Income (loss) per share, diluted
  $ 0.02     $ (1.06 )   $ (0.18 )   $ (1.53 )
                                 
Weighted average number of shares outstanding:
                               
Basic
    14,617,235       11,934,705       13,854,860       11,300,757  
Diluted
    23,430,416       11,934,705       13,854,860       11,300,757  
 
See notes to Condensed Consolidated Financial Statements.

 
4

 

eMAGIN CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN CAPITAL DEFICIT
(In thousands)
(unaudited)


         
Additional
         
Total
 
   
Common Stock
   
Paid-In
   
Accumulated
   
Shareholders’
 
   
Shares
   
Amount
   
Capital
   
Deficit
   
Deficit
 
                               
                               
Balance, December 31, 2007 as reported
    12,621     $ 12     $ 195,326     $ (199,313 )   $ (3,975 )
Adjustments      (163 )     -       (195 )           (195 )
Adjusted balance      12,458       12       195,131       (199,313 )     (4,170 )
Sale of common stock, net of issuance costs
    1,587       2       1,578             1,580  
Expiration of put option      125             150             150  
Issuance of common stock for services
    326             303             303  
Stock-based compensation
                845             845  
Fair value of warrants issued
                883             883  
Deemed dividend, put option                 (44  )           (44 )
Net loss
                      (2,435 )     (2,435 )
Balance, September 30, 2008
    14,496     $ 14     $ 198,846     $ (201,748 )   $ (2,888 )
 
 
 
See notes to Condensed Consolidated Financial Statements.


 
5

 

eMAGIN CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

   
Nine months Ended
 
   
September 30,
 
   
2008
   
2007
 
   
(unaudited)
 
Cash flows from operating activities:
           
Net loss
  $ (2,435 )   $ (17,316 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
Depreciation and amortization
    183       313  
Amortization of deferred financing and waiver fees
    1,152       266  
Increase in (reduction of) provision for sales returns and doubtful accounts
    241       (35 )
Stock-based compensation
    845       1,172  
Amortization of common stock issued for services
    88       953  
Amortization of discount on notes payable
    25       1,848  
Loss on warrant derivative liability
          853  
Loss on extinguishment of debt
          10,749  
                 
Changes in operating assets and liabilities:
               
Accounts receivable
    (1,860 )     (1,755 )
Inventory
    (163 )     534  
Prepaid expenses and other current assets
    254       (145 )
Deferred revenue
    (54 )     128  
Accounts payable, accrued compensation, other accrued expenses, and advance payments
    94       750  
Other current liabilities
    (277 )     15  
Net cash used in operating activities
    (1,908 )     (1,670 )
                 
Cash flows from investing activities:
               
Purchase of equipment
    (236 )     (9 )
Proceeds from investments – held to maturity
          33  
      Net cash (used in) provided by investing activities
    (236 )     24  
                 
Cash flows from financing activities:
               
Proceeds from sale of common stock, net of issuance costs
    1,580        
Proceeds from exercise of warrants
          3  
Proceeds from debt
    1,934       1,108  
Payments related to deferred financing costs
    (117 )     (40 )
Payments of debt and capital leases
    (694 )     (48 )
Net cash provided by financing activities
    2,703       1,023  
                 
Net increase (decrease) in cash and cash equivalents
    559       (623 )
Cash and cash equivalents beginning of period
    713       1,415  
Cash and cash equivalents end of period
  $ 1,272     $ 792  
                 
Cash paid for interest
  $ 524     $ 281  
Cash paid for taxes
  $ 31     $ 67  
 
Non-cash financing and investing activities:
 
During the nine months ended September 30, 2008, the Company:
               
   
· Entered into an amended Loan and Security Agreement and issued warrants that are exercisable at $1.50 per share into 1.0 million shares of common stock valued at approximately $0.7 million.
 
· Entered into an amended Loan and Security Agreement and issued warrants that are exercisable at $1.30 per share into 370,000 shares of common stock valued at approximately $154,000.
 

See notes to Condensed Consolidated Financial Statements.

 
6

 


eMAGIN CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 (Unaudited)

Note 1:  Description of the Business and Summary of Significant Accounting Policies

The Business

eMagin Corporation (the “Company”) designs, develops, manufactures, and markets virtual imaging products for consumer, commercial, industrial and military applications.  The Company’s products are sold mainly in North America, Asia, and Europe.

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements of eMagin Corporation and its subsidiary reflect all adjustments, including normal recurring accruals, necessary for a fair presentation.  Certain information and footnote disclosure normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the Securities and Exchange Commission.  The Company believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2007.  The results of operations for the period ended September 30, 2008 are not necessarily indicative of the results to be expected for the full year.

The unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.  The Company has had recurring losses from operations, which it believes will continue through the foreseeable future.  The Company’s cash requirements over the next twelve months are greater than the Company’s current cash, cash equivalents, and investments at September 30, 2008.  The Company has working capital and capital deficits as of September 30, 2008. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern without continuing to obtain additional funding.  The Company does not have commitments for such financing and no assurance can be given that additional financing will be available, or if available, will be on acceptable terms. If the Company is unable to obtain sufficient funds during the next twelve months, the Company will further reduce the size of its organization and/or curtail operations which will have a material adverse impact on the Company’s business prospects. The Company is reviewing its cost structures for cost efficiencies and is taking measures to reduce costs. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 
Use of Estimates

In accordance with accounting principles generally accepted in the United States of America, management utilizes certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments. Management bases its estimates and judgments on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.

Revenue Recognition

Revenue is recognized when products are shipped to customers, net of allowances for anticipated returns.  The Company’s revenue-earning activities generally involve delivering products. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, selling price is fixed or determinable and collection is reasonably assured.  

The Company also earns revenues from certain R&D activities under both firm fixed-price contracts and cost-type contracts, including some cost-plus-fee contracts.  Revenues on cost-plus-fee contracts include costs incurred plus a portion of estimated fees or profits based on the relationship of costs incurred to total estimated costs. Contract costs include all direct material and labor costs and an allocation of allowable indirect costs as defined by each contract, as periodically adjusted to reflect revised agreed upon rates. These rates are subject to audit by the other party. 
 
7


Note 2:  Recently Issued Accounting Pronouncements
 
In September 2006, the FASB issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements,” (“SFAS 157”), which defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and expands disclosures about fair value measurements. SFAS 157 does not require any new fair value measurements, but provides guidance on how to measure fair value by providing a fair value hierarchy used to classify the source of the information. In February 2008, the FASB issued FASB Staff Position No. FSP 157-2, “Effective Date of FASB Statement No. 157”, which provides a one year deferral of the effective date of SFAS 157 for non-financial assets and non-financial liabilities, except those that are recognized or disclosed in the financial statements at fair value on a recurring basis. The Company adopted SFAS 157 as of January 1, 2008, with the exception of the application of the statement to non-recurring non-financial assets and non-financial liabilities for which it will defer the adoption until January 1, 2009. In October 2008, the FASB issued FASP FAS 157-3, “Determining the Fair Value of a Financial Asset When the Market for That Asset Is Not Active” (“FSP 157-3”). FSP 157-3 clarified the application of FAS 157 in situations where the market for that financial asset is not active.  FSP 157-3 was effective upon issuance, including prior periods for which financial statements had not been issued. The adoption of SFAS 157 did not have a material impact on the Company’s consolidated results of operations, financial condition or cash flows.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — including an amendment of FASB Statement No. 115,” (“SFAS 159”) which is effective for fiscal years beginning after November 15, 2007. This statement permits entities to choose to measure many financial instruments and certain other items at fair value. This statement also establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. Unrealized gains and losses on items for which the fair value option is elected would be reported in earnings. The Company has adopted SFAS 159 and has elected not to measure any additional financial instruments and other items at fair value and therefore the adoption of SFAS 159 did not have a material impact on the Company’s condensed consolidated results of operations, financial condition or cash flows.

In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161, Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133 (“SFAS 161”). SFAS 161 requires entities to provide greater transparency about (a) how and why an entity uses derivative instruments, (b) how derivative instruments and related hedged items are accounted for under Statement 133 and its related interpretations and (c) how derivative instruments and related hedged items affect an entity’s financial position, results of operations, and cash flows. SFAS 161 is effective prospectively for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with early application permitted. The Company is currently evaluating the disclosure implications of this statement.
 
In May 2008, the FASB issued SFAS No. 162, The Hierarchy of Generally Accepted Accounting Principles, (“SFAS 162”), which identifies the sources of accounting principles and the framework for selecting principles to be used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles in the United States. This statement shall be effective 60 days following the SEC's approval of the Public Company Accounting Oversight Board's amendments to AU section 411, The Meaning of Present Fairly in Conformity with Generally Accepted Accounting Principles. The Company is currently evaluating the impact of SFAS 162, but does not expect the adoption of this pronouncement will have a material impact on the Company's financial statements.

Note 3:  Receivables
 
The majority of the Company’s commercial accounts receivable are due from Original Equipment Manufacturers ("OEM’s”). Credit is extended based on evaluation of a customer’s financial condition and, generally, collateral is not required. Accounts receivable are payable in U.S. dollars, are due within 30-90 days and are stated at amounts due from customers, net of an allowance for doubtful accounts. Any account outstanding longer than the contractual payment terms is considered past due.
 
8


The Company determines the allowance for doubtful accounts by considering a number of factors, including the length of time the trade accounts receivable are past due, eMagin's previous loss history, the customer's current ability to pay its obligation, and the condition of the general economy and the industry as a whole.   The Company will record a specific reserve for individual accounts when the Company becomes aware of a customer's inability to meet its financial obligations, such as in the case of bankruptcy filings or deterioration in the customer's operating results or financial position.  If circumstances related to customers change, the Company would further adjust estimates of the recoverability of receivables.

Receivables consisted of the following (in thousands):

   
September 30,
 2008
(unaudited)
   
December 31, 2007
 
Accounts receivable
  $ 4,600     $ 2,741  
Less allowance for doubtful accounts
    (598 )     (358 )
Net receivables 
  $ 4,002     $ 2,383  

Note 4:  Research and Development Costs

Research and development costs are expensed as incurred.

Note 5:  Net Loss per Common Share

In accordance with SFAS No. 128, net loss per common share amounts ("basic EPS") is computed by dividing net loss by the weighted average number of common shares outstanding and excluding any potential dilution.  Net loss per common share assuming dilution ("diluted EPS") is computed by reflecting potential dilution from the exercise of stock options, warrants, convertible notes and redeemable stock.
 
The following table presents a reconciliation of the numerator and denominators of the basic and diluted EPS calculations (in thousands, except share and per share data):

   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2008
   
2007
   
2008
   
2007
 
Numerator:
                       
                         
Net earnings
  $ 361     $ (12,651 )   $ (2,435 )   $ (17,316 )
Adjustment for interest expense on convertible notes, net of taxes
    121                          
Net earnings (loss), adjusted
  $ 482     $ (12,651 )   $ (2,435 )   $ (17,316 )
                                 
Denominator:
                               
Weighted average shares outstanding for basic earning per share
    14,617,235       11,934,705       13,854,860       11,300,757  
Effective of dilutive shares:
                               
    Dilution from stock options and warrants
    365,216                    
    Redeemable stock
    117,277                    
    Convertible notes
    8,330,688                    
Dilutive potential common shares
    8,813,181                    
Weighted –average shares outstanding for diluted earnings per share
    23,430,416       11,934,705       13,854,860       11,300,757  

The Company excludes options and warrants with exercise prices that are greater than the average market price from the calculation of diluted EPS whose effect would be anti-dilutive.  For the three months ended September 30, 2008, the Company excluded 11,680,679 from its diluted EPS calculation as their effect would be anit-dilutive.
 
For the nine months ended September 30, 2008 and the three and nine months ended September 30, 2007, the Company has excluded options, warrants, and convertible notes outstanding to acquire 10,901,343 and 17,440,096 shares of our common stock, respectively, since their effect would be anti-dilutive.
 
9


The Company issued 522,500 shares of common stock which were redeemable.  Of the 522,500 shares, 360,000 shares were excluded as the shares have a redemption price below the average market price and would be anti-dilutive. Of the remaining 162,500 shares which were “in the money”, only the incremental shares, 117,277, were included.

The convertible notes are convertible at the option of the holders at any time prior to maturity.  For purposes of calculating diluted earnings per share, the interest expense associated with the notes was added back to net earnings and the shares issuable upon conversion of the notes were included.

Note 6:  Inventory

Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out method.  The Company reviews the value of its inventory and reduces the inventory value to its net realizable value based upon current market prices and contracts for future sales. The components of inventories are as follows (in thousands):

   
September 30,
 2008
 (unaudited)
   
December 31, 2007
 
Raw materials 
  $ 1,175     $ 1,069  
Work in process
    157       370  
Finished goods 
    646       376  
Total inventory
  $ 1,978     $ 1,815  

Note 7:  Prepaid Expenses and Other Current Assets:

Prepaid expenses and other current assets consist of the following (in thousands):
 
   
September 30,
 2008
 (unaudited)
   
December 31, 2007
 
Vendor prepayments
  $ 344     $ 537  
Other prepaid expenses
    364       310  
Other assets
    3       3  
Total prepaid expenses and other current assets
  $ 711     $ 850  
 
Note 8:  Debt

Debt is as follows (in thousands):
 
   
September 30,
       
   
2008
(unaudited)
   
December 31,
2007
 
Current portion of long-term debt:
           
     Other debt
  $ 31     $ 44  
      Line of credit with Moriah
    2,382       1,108  
      8% Senior Secured Convertible Notes
    5,962       5,962  
          Less:  Unamortized discount on notes payable
          (25 )
      Current portion of long-term debt, net
    8,375       7,089  
Long-term debt:
               
     Other debt
    38       60  
       Long-term debt, net
    38       60  
Total debt, net
  $ 8,413     $ 7,149  

On August 7, 2007, the Company entered into a loan agreement with Moriah Capital, L.P. (“Moriah”) and established a revolving line of credit (the “Loan”) of $2.5 million.  The Company is permitted to borrow an amount not to exceed 90% of its domestic eligible accounts receivable and 50% of its eligible inventory capped at $600 thousand.  As part of the transaction, the Company issued 162,500 shares of unregistered common stock valued at $195 thousand and paid a servicing fee of $82.5 thousand to Moriah which are amortized to interest expense over the life of the agreement. In conjunction with entering into this loan and issuing unregistered common stock, the Company granted Moriah registration rights.  The Loan is convertible into shares of the Company’s common stock pursuant to the terms of the Loan Conversion Agreement.  The Loan was to mature on August 7, 2008, however Moriah extended the maturity date to August 20, 2008 when the loan agreement was further amended as explained below.
 
10


On January 30, 2008, the Company amended and restated its Loan agreement (“Amended Loan Agreement”) with Moriah.  The Amended Loan Agreement’s borrowing base calculation was modified to include 70% of eligible foreign accounts.  The Amended Loan Agreement eliminated the optional conversion of principal up to $2.0 million into common stock.  In connection with the amendment, the Company issued a Warrant to purchase 750,000 shares of its common stock at a price of $1.50 per share with an expiration date of January 29, 2013.

The Amended Loan Agreement has specific terms to which the Company must comply including (a) maintaining a lockbox account into which payments from related accounts receivable must be deposited, (b) periodic certifications as to borrowing base amounts equaling or exceeding net balances outstanding under the Line of Credit, and (c) a requirement that a registration statement with respect to shares held or to be issued to the lender be filed within thirty days of January 30, 2008.  A delay in establishing the required lockbox account created a technical default under the Line of Credit agreement.  Similarly, the production and subsequent discovery of defective displays resulted in an inadvertent overstatement of inventory during December, January and early February that created a technical default under the agreement.  Finally, the Company was not able to complete the registration of shares within the thirty day timeframe mandated in the amended agreement.  On March 25, 2008 the Company received a waiver from the lender (a) waiving compliance with the lockbox account requirement through March 14, 2008, (b) waiving compliance with the borrowing base requirement in so far as it related exclusively to the defective displays inadvertently included in inventory, and (c) extending the period for filing a registration statement for certain shares held or to be issued to the lender until April 29, 2008.  The Company established a lockbox account by March 14, 2008 and filed a registration statement with the SEC on April 29, 2008.

Effective March 25, 2008, the Company amended the Warrant Issuance Agreement (“Amended Warrant Agreement”) with Moriah. In connection with such amendment, the Company issued a waiver fee in the form of a Warrant to purchase an additional 250,000 shares of its common stock at a price of $1.50 expiring March 25, 2013.

The Company determined the fair value of the 1,000,000 warrants to be $729 thousand of which $168 thousand was expensed immediately and $561 thousand will be amortized to interest expense over the life of the loan.  The following assumptions were used to determine the fair value of the warrants:  dividend yield of 0%; risk free interest rates of 2.61 % and 2.96%; expected volatility of 90.9% and 92.3%; and expected contractual term of 5 years.

The Company and Moriah entered into Amendment No. 3 to the Loan and Security Agreement dated August 20, 2008 (the “Amendment No. 3”).  Pursuant to Amendment No. 3, the Company issued Moriah an Amended and Restated Revolving Loan Note (the “Amended Note”) and the maturity date has been extended to August 7, 2009. The Company will pay Moriah $85 thousand in servicing fees by December 1, 2008 and as of September 30, 2008, the Company has paid $34 thousand.  The servicing fees will be amortized to interest expense over the life of the agreement.

Pursuant to Amendment No. 3, the following changes were made to the Loan:  the maximum amount the Company can borrow has been increased to $3 million; the borrowing base calculation was modified to increase eligible foreign accounts receivable to 80% and increased the eligible inventory to the lesser of 70% or $800 thousand; and financial covenants have been added.

The Company issued Moriah a warrant, which terminates on August 7, 2013, to purchase up to 370,000 shares of the Company’s common stock at an exercise price of $1.30 per share.  The Company determined the fair value of the warrants to be approximately $154 thousand which was recorded as a deferred debt issuance cost. The following assumptions were used to determine the fair value of the warrants:  dividend yield of 0%; risk free interest rates of 3.16 %; expected volatility of 87.7%; and expected contractual term of 5 years.  The deferred debt issuance costs are being amortized to interest expense over the life of the loan.
 
11


Pursuant to Amendment No. 3, the Company and Moriah, also, entered into an Amended and Restated Securities Issuance Agreement.  The Company issued 485,000 shares of unregistered common stock valued at approximately $340 thousand which was recorded as a deferred debt issuance cost.  It will be amortized to interest expense over the life of the agreement. In addition, the holders of the Amended 8% Notes and the investors in the Purchase Agreement (See Note 10) consented to the Amended Note and received a total of 144,000 shares of unregistered common stock valued at approximately $101 thousand which was recorded as waiver fees and expensed to interest expense.

Pursuant to Amendment No. 3, the Company and Moriah entered into an Amendment to Registration Rights Agreement (the “Amended Registration Rights Agreement”).   Pursuant to the Amended Registration Rights Agreement, the Company agreed to use its best efforts to file a registration statement  to register the shares 485,000 shares of the company’s common stock issued pursuant to the Amended and Restated Securities Issuance Agreement and the shares of common stock issuable upon exercise of the Warrant, provided that the Company is permitted to under applicable securities rules and regulations and after the certain other registration statements that the Company was obligated to file on behalf of selling shareholders have been  declared effective.

In the three and nine months ended September 30, 2008, approximately $331 thousand and $1.2 million, respectively, of deferred debt issuance costs and waiver fees were amortized to interest expense.  For the three and nine months ended September 30, 2008, interest expense includes interest paid or accrued on outstanding debt of approximately $178 thousand and $501 thousand, respectively.

The 8% Senior Secured Convertible Notes can also convert into the Company’s Series A Convertible Preferred Stock (the “Preferred Stock”).  See Note 10:  Shareholders’ Equity for additional information.

Note 9:  Stock-based Compensation

The Company accounts for the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors under Statement of Financial Accounting Standards No. 123 (revised 2004), Share-Based Payment, (SFAS 123(R)). Under SFAS 123(R), the fair value of stock awards is estimated at the date of grant using the Black-Scholes option valuation model.  Stock-based compensation expense is reduced for estimated forfeitures and is amortized over the vesting period using the straight-line method.

The following table summarizes the allocation of non-cash stock-based compensation to our expense categories for the three and nine-month periods ended September 30, 2008 and 2007 (in thousands):

   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2008
   
2007
   
2008
   
2007
 
Cost of revenue
  $ 31     $ 43     $ 106     $ 173  
Research and development
    58       82       192       282  
Selling, general and administrative
    149       148       547       717  
Total stock compensation expense
  $ 238     $ 273     $ 845     $ 1,172  

At September 30, 2008, total unrecognized non-cash compensation cost related to stock options was approximately $964 thousand, net of forfeitures.  Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures and is expected to be recognized over a weighted average period of approximately 1.7 years.

The Company recognizes compensation expense for options granted to non-employees in accordance with the provisions of Emerging Issues Task Force (“EITF”) consensus Issue 96-18, “Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling Goods or Services,” which requires using a fair value options pricing model and re-measuring such stock options to the current fair market value at each reporting period as the underlying options vest and services are rendered.

There were approximately 171,000 and 919,000 options granted to employees and directors during the three and nine months ended September 30, 2008. The following key assumptions were used in the Black-Scholes option pricing model to determine the fair value of stock options granted:
 
   
For the Nine Months Ended
September 30
 
   
2008
   
2007
 
Dividend yield
    0 %     0 %
Risk free interest rates
 
2.46 to 3.37%
      4.23 %
Expected  volatility
 
88.4 to 92.3%
      106 %
Expected term (in years)
    5       5  

12


There were no stock options granted during the three and nine-month period ended September 30, 2007.  We have not declared or paid any dividends and do not currently expect to do so in the near future.  The risk-free interest rate used in the Black-Scholes option pricing model is based on the implied yield currently available on U.S. Treasury securities with an equivalent term.   Expected volatility is based on the weighted average historical volatility of the Company’s common stock for the most recent five year period.  The expected term of options represents the period that our stock-based awards are expected to be outstanding and was determined based on historical experience and vesting schedules of similar awards.

The Board of Directors authorized the establishment of the 2008 Incentive Stock Plan with 2,000,000 options available for grant.  The 2008 Incentive Stock Plan is intended to provide long-term performance incentives to directors, executives, selected employees and consultants and reward them for making major contributions to the success and well being of the Company.  No options were granted from this plan as of September 30, 2008.

A summary of the Company’s stock option activity for the nine months ended September 30, 2008 is presented in the following tables:
 
   
Number of Shares
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual Life (In Years)
   
Aggregate Intrinsic Value
 
Outstanding at January 1, 2008
    894,323     $ 2.62              
Options granted
    919,253       0.89              
Options exercised
                         
Options forfeited
    (205,903 )     2.29              
Options cancelled
                         
Outstanding at September 30, 2008
    1,607,673     $ 1.63       6.67     $  
Vested or expected to vest at September 30, 2008 (1)
    1,569,232     $ 1.55       6.67     $  
Exercisable at September 30, 2008
    1,127,170     $ 1.76       6.91     $  

     
Options Outstanding
   
Options Exercisable
 
     
Number Outstanding
   
Weighted Average Remaining Contractual Life (In Years)
   
Weighted Average Exercise Price
   
Number Exercisable
   
Weighted Average Exercisable Price
 
$ 0.81 - $1.51       1,140,130       8.09     $ 1.00       763,017     $ 1.08  
$ 2.60 - $2.70       430,343       3.23       2.61       333,153       2.60  
$ 3.50 - $5.80       8,000       3.81       5.51       8,000       5.51  
$ 6.60 - $22.50       29,200       2.82       10.91       23,000       10.82  
          1,607,673       6.67     $ 1.63       1,127,170     $ 1.76  

(1) The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.

The aggregate intrinsic value in the table above represents the difference between the exercise price of the underlying options and the quoted price of the Company’s common stock.  There were no options in-the-money at September 30, 2008.   The Company’s closing stock price was $0.54 as of September 30, 2008. The Company issues new shares of common stock upon exercise of stock options.

 
13

 
 
Note 10:  Shareholders’ Equity

Preferred Stock

The Company has designated but not issued 3,198 shares of the Company’s Preferred Stock at a stated value of $1,000 per share.  The Preferred Stock is entitled to cumulative dividends which accrue at a rate of 8% per annum, payable on December 21, 2008.  Each share of the Preferred Stock has voting rights equal to (1)  in any case in which the Preferred Stock votes together with the Company's Common Stock or any other class or series of stock of the Company, the number of shares of Common Stock issuable upon conversion of such shares of Preferred Stock at such time (determined without regard to the shares of Common Stock so issuable upon such conversion in respect of accrued and unpaid dividends on such share of Preferred Stock) and (2) in any case not covered by the immediately preceding clause one vote per share of Preferred Stock.  The Preferred Stock, if issued, has a mandatory redemption at December 21, 2008.

Common Stock

On January 30, 2008, the Company amended and restated its Loan and Security Agreement (“Amended Loan Agreement”) with Moriah.   As part of the amended agreement, the Loan Conversion agreement was terminated which eliminated the optional conversion of principal up to $2.0 million into common stock at $1.50.  In connection with the Amended Loan agreement, the Company issued a Warrant to purchase 750,000 shares of its common stock at a price of $1.50 per share with an expiration date of January 29, 2013.

Effective March 25, 2008, the Company amended the Warrant Issuance Agreement (“Amended Warrant Agreement”) with Moriah. In connection with such amendment, the Company issued a Warrant to purchase an additional 250,000 shares of its common stock at a price of $1.50 expiring March 25, 2013.

On April 2, 2008, the Company entered into a Securities Purchase Agreement (“Purchase Agreement”), pursuant to which the Company sold and issued 1,586,539 shares of common stock, par value of $0.001 per share, at a price of $1.04 per share and warrants to purchase an additional 793,273 shares of common stock for an aggregate purchase price of approximately $1.65 million.  The net proceeds received after expenses were approximately $1.58 million.  The warrants are exercisable at a price of $1.30 per share and expire on April 2, 2013.

As a result of the Purchase Agreement, the outstanding 650,000 Series F Common Stock Purchase Warrants that were issued to participants of the Securities Purchase Agreement dated October 25, 2004, were repriced from $4.09 to $3.45.

A registration rights agreement was entered into on April 2, 2008 in connection with the private placement which required the Company to file a registration statement for the resale of the common stock and the shares underlying the warrants within 45 days of the signing of the agreement.  The Company must use its best efforts to have the registration statement declared effective within 90 days of the signing of the agreement or if a SEC review occurs, 120 days.  In addition, the Company must use its best efforts to maintain the effectiveness of the registration statement until all common stock has been sold or may be sold without volume restrictions pursuant to Rule 144(k) of the Securities Act.

If the registration statement is not effective within the grace periods (“Event Date”) or the Company cannot maintain its effectiveness (“Event Date”), the Company must pay partial liquidated damages (“damages”) in cash to each investor equal to 2% of the aggregate purchase price paid by each investor under the Purchase Agreement on the Event Date and each monthly anniversary of the Event Date (or on a pro-rata basis for any portion of a month) until the registration statement is effective.  The Company is not liable for any damages with respect to the warrants or warrant shares.  The maximum damages payable to each investor is 36% of the aggregate purchase price.  If the Company fails to pay the damages to the investors within 7 days after the date payable, the Company must pay interest at a rate of 15% per annum to each investor which accrues daily from the date payable until damages are paid in full.

The Company filed the registration statement within the 45 day period however the Company was notified that the registration statement was under review by the SEC.  The amended registration statement was not filed by August 2, 2008 which was the 120th day from the signing of the purchase agreement and therefore the registration statement is not effective. As of September 30, 2008, the registration statement is not effective.

The Company accounted for the registration payment arrangement under the guidance of EITF 00-19-2, “Accounting for Registration Payment Arrangements”, (“EITF 00-19-2”) which requires the contingent obligation to make future payments be recognized and measured in accordance with FASB Statement No. 5, “Accounting for Contingencies”, (“Statement 5”) and FASB Interpretation No. 14, “Reasonable Estimation of the Amount of a Loss”, (“Interpretation 14”). The Company estimated $399 thousand to be the maximum potential damages that the Company may be required to pay the investors if the registration statement is not effective within three years of the signing of the agreement. The Company estimated $126 thousand to be a reasonable estimate of the potential damages that may be due to the investors.  As a result, the Company recorded a liability of $126 thousand in the condensed consolidated balance sheets and the associated expense in other income (expense) in the condensed consolidated statements of operations of approximately $60 thousand and $126 thousand for the three and nine months ended September 30, 2008, respectively.
 
14


On August 20, 2008, the Company and Moriah Capital entered into Amendment No. 3 to the Loan and Security Agreement (“Amendment No. 3”) effective August 7, 2008. The Company issued Moriah a warrant, which terminates on August 7, 2013, to purchase up to 370,000 shares of the Company’s common stock at an exercise price of $1.30 per share.

In addition, the Company and Moriah entered into an Amended and Restated Securities Issuance agreement (the “Amended and Restated Securities Issuance Agreement”) on August 20, 2008. On August 7, 2007, in connection with the Securities Issuance Agreement, (the “Original Securities Issuance Agreement”), the Company issued Moriah 162,500 shares of the Company’s common stock (the “2007 Shares”). With respect to the Amended and Restated Securities Issuance Agreement, Moriah agreed to waive the Company’s obligation to buy back the 2007 Shares with respect to 125,000 of such shares and to defer the Company’s obligation to buy back 37,500 of such 2007 Shares  (collectively, the “Put Waiver”). The Company issued Moriah 485,000 shares of its Common Stock (of which 125,000 shares were issued in consideration for the Put Waiver from Moriah and 360,000 shares were issued in lieu of the issuance to Moriah of the Contingent Issued Shares (as described in the Original Securities Issuance Agreement)). Additionally, the Company has granted Moriah a put option pursuant to which Moriah can sell to the Company 162,500 shares of its common stock for $195,000, pro-rated for any portion thereof (the “2007 Put Price”) and a second put option pursuant to which Moriah can sell 360,000 of the shares issued to Moriah to the Company for $234,000 (the “2008 Put Option”).  The 2007 and 2008 Put Option shall automatically be deemed exercised by Moriah unless Moriah delivers written notice to the Company at any time between July 1, 2009 and August 1, 2009 that Moriah does not wish to exercise the 2008 Put option in whole or in part.
 
The shares underlying the put options are presented as redeemable common stock and presented separately from permanent equity. As of September 30, 2008, an aggregate  of 522,500 shares related to the 2007 and 2008 put options are presented on the balance sheet as redeemable common stock in the amount of $429,000, representing the amount for which the shares may be redeemed at the option of the holders at such date.
 
We have restated the December 31, 2007 balance sheet with respect to 162,500 shares of common stock underlying the 2007 put option, in the amount of $195,000, representing the amount for which the shares may be redeemed at the option of the holders at such date. Such shares, which were previously reported as permanent equity, (“capital deficit”) are presented as redeemable common stock on the accompanying balance sheet.
 
The Company and Moriah entered into an Amendment to Registration Rights Agreement (the “Amended Registration Rights Agreement”) and the Company agreed to use its best efforts to file a registration statement to register the 485,000 shares of the Company’s common stock issued and the shares of common stock issuable upon exercise of the Warrant.
 
On August 19, 2008, the Holders of the Amended Notes and the Investors in the Purchase Agreement consented to the Company’s execution of the Amended Note, Amendment No. 3, Amended and Restated Securities Issuance Agreement, and the Amended Registration Rights Agreement.  In consideration for the consent, a total of 144,000 shares of common stock were issued to the Holders and Investors based on individual participation in the Amended Notes and Purchase Agreement on September 4, 2008.
 
For the three and nine months ended September 30, 2008 and 2007, there were no stock options exercised.  For the three and nine months ended September 30, 2008, there were no warrants exercised and for the three months ended September 30, 2007, there were no warrants exercised and for the nine months ended September 30, 2007, the Company received approximately $3 thousand in proceeds for warrants exercised.
 
For the three and nine months ended September 30, 2008, the Company issued approximately 629,000 and 811,000 shares of common stock, respectively, for payment of approximately $441 thousand  and $643 thousand, respectively, for services rendered or to be rendered in the future.  For the three and nine months ended September 30, 2007, the Company issued approximately 163 thousand and 1.1 million shares of common stock, respectively, for payment of approximately $195 thousand and $953 thousand, respectively, for services rendered and to be rendered in the future.  As such, the Company recorded the fair value of the services to be rendered in prepaid expenses and rendered in selling, general and administrative expenses in the accompanying unaudited condensed consolidated statement of operations for the three and nine months ended September 30, 2008 and 2007, respectively.
 
Note 11:  Income Taxes
 
The Company adopted the provisions of Financial Standards Accounting Board Interpretation No. 48 Accounting for Uncertainty in Income Taxes (“FIN 48”) an interpretation of FASB Statement No. 109 (“SFAS 109”) on January 1, 2007. As a result of the implementation of FIN 48, we did not recognize any adjustment in the liability for unrecognized income tax benefits. The tax years 2004-2007 remain open to examination by the major taxing jurisdictions to which we are subject. In the event that the Company is assessed interest or penalties at some point in the future, they will be classified in the financial statements as general and administrative expense.  The Company has not provided for income taxes in the three and nine months ended September 30, 2008 as the Company expects its effective tax rate to be zero due to continuing losses.
 
15

 
Note 12:  Commitments and Contingencies

Royalty Payments

The Company, in accordance with a royalty agreement with Eastman Kodak, must pay to Eastman Kodak a certain percentage of net sales with respect to certain products, which percentages are defined in the agreement. The percentages are on a sliding scale depending on the amount of sales generated. Any minimum royalties paid will be credited against the amounts due based on the percentage of sales. The royalty agreement terminates upon the expiration of the issued patent which is the last to expire.

Effective May 30, 2007, Kodak and eMagin entered into an intellectual property agreement where eMagin has assigned Kodak the rights, title, and interest to a Company owned patent currently not being used by the Company and in consideration, Kodak waived the royalties due under the existing licensing agreements for the first six months of 2007, and reduced the royalty payments by 50% for the second half of 2007 and for the entire calendar year of 2008. In addition, the minimum royalty payment is delayed until December 1st for the years 2007 and 2008.  The Company recorded approximately $142 thousand and $396 thousand for the three and nine months ended September 30, 2008, respectively, and approximately $163 thousand and $723 thousand for the three and nine months ended September 30, 2007 as income from the license of intangible assets and included this amount as other income in the condensed consolidated statements of operations.  The income from the license of intangible assets is equivalent to the royalty payments that have been waived by Kodak.

Royalty expense (including amounts imputed – see above) was approximately $284 thousand and $792 thousand, respectively, for the three and nine months ended September 30, 2008 and approximately $327 thousand and $887 thousand, respectively, for the three and nine months ended September 30, 2007.

Contractual Obligations

The Company leases office facilities and office, lab and factory equipment under operating leases expiring through 2009.  Certain leases provide for payments of monthly operating expenses. The Company currently has lease commitments for space in Hopewell Junction, New York and Bellevue, Washington.  Rent expense was approximately $332 thousand and $996 thousand, respectively, for the three and nine months ended September 30, 2008 and 2007.

Note 13:  Legal Proceedings

A former employee (“plaintiff”) of the Company commenced legal action in the United States District Court for the Southern District of New York, on or about October 12, 2007, alleging that the plaintiff was subject to gender based discrimination and retaliation in violation of Title VII of the Civil Rights Act of 1964 (Case No. 07-CV-8827 (KMK)). The plaintiff seeks unspecified compensatory damages, punitive damages and attorneys’ fees.  On November 26, 2007, the Company served and filed its Answer, in which it denied the material allegations of the Complaint and asserted numerous affirmative defenses.  This action is presently in the discovery stage.  The Company disputes the allegations of the Complaint and intends on vigorously defending this action.

 
16

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statement of Forward-Looking Information

In this quarterly report, references to "eMagin Corporation," "eMagin," "Virtual Vision," "the Company," "we," "us," and "our" refer to eMagin Corporation and its wholly owned subsidiary, Virtual Vision, Inc. Except for the historical information contained herein, some of the statements in this Report contain forward-looking statements that involve risks and uncertainties.  These statements are found in the sections entitled "Management's Discussion and Analysis or Plan of Operations" and "Risk Factors."  They include statements concerning: our business strategy; expectations of market and customer response; liquidity and capital expenditures; future sources of revenues; expansion of our proposed product line; and trends in industry activity generally.  In some cases, you can identify forward-looking statements by words such as "may," "will," "should," "expect," "plan," "could," "anticipate," "intend," "believe," "estimate," "predict," "potential," "goal," or "continue" or similar terminology.  These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including, but not limited to, the risks outlined under "Risk Factors," that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements.  For example, assumptions that could cause actual results to vary materially from future results include, but are not limited to: our ability to successfully develop and market our products to customers; our ability to generate customer demand for our products in our target markets; the development of our target markets and market opportunities; our ability to manufacture suitable products at competitive cost; market pricing for our products and for competing products; the extent of increasing competition; technological developments in our target markets and the development of alternate, competing technologies in them; and sales of shares by existing shareholders.  Although we believe that the expectations reflected in the forward looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.  Unless we are required to do so under federal securities laws or other applicable laws, we do not intend to update or revise any forward-looking statements.

Overview

We design, develop, manufacture, and market virtual imaging products which utilize OLEDs, or organic light emitting diodes, OLED-on-silicon microdisplays and related information technology solutions.  We integrate OLED technology with silicon chips to produce high-resolution microdisplays smaller than one-inch diagonally which, when viewed through a magnifier, create virtual images that appear comparable in size to that of a computer monitor or a large-screen television.  Our products enable our original equipment manufacturer, or OEM, customers to develop and market improved or new electronic products.  We believe that virtual imaging will become an important way for increasingly mobile people to have quick access to high-resolution data, work, and experience new more immersive forms of communications and entertainment.

Our first commercial product, the SVGA+ (Super Video Graphics Array of 800x600 plus 52 added columns of data) OLED microdisplay, was initially offered for sampling in 2001, and our first SVGA-3D (Super Video Graphics Array plus built-in stereovision capability) OLED microdisplay was shipped in early 2002.  We are in the process of completing development of 2 additional OLED microdisplays, namely the SVGA 3DS (SVGA 3D shrink, a smaller format SVGA display with a new cell architecture with embedded features) and an SXGA (1280 x 1024).

We license our core OLED technology from Eastman Kodak and we have developed our own technology to create high performance OLED-on-silicon microdisplays and related optical systems.  We believe our technology licensing agreement with Eastman Kodak, coupled with our own intellectual property portfolio, gives us a leadership position in OLED and OLED-on-silicon microdisplay technology.  We believe we are the only company to sell full-color active matrix small molecule OLED-on-silicon microdisplays.

Company History

Historically, we have been a developmental stage company. As of January 1, 2003, we were no longer classified as a development stage company. We have transitioned to manufacturing our product and intend to significantly increase our marketing, sales, and research and development efforts, and expand our operating infrastructure. Currently, most of our operating expenses are fixed. If we are unable to generate significant revenues, our net losses in any given period could be greater than expected.
 
17


CRITICAL ACCOUNTING POLICIES

The Securities and Exchange Commission ("SEC") defines "critical accounting policies" as those that require application of management's most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all of the accounting policies require management to make difficult, subjective or complex judgments or estimates.  However, the following policies could be deemed to be critical within the SEC definition.

Revenue Recognition

Revenue is recognized when products are shipped to customers, net of allowances for anticipated returns.  The Company’s revenue-earning activities generally involve delivering products. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, selling price is fixed or determinable and collection is reasonably assured.

The Company also earns revenues from certain R&D activities under both firm fixed-price contracts and cost-type contracts, including some cost-plus-fee contracts.  Revenues on firm fixed-price contracts are recognized as costs are incurred (cost-to-cost basis).  Revenues on cost-plus-fee contracts include costs incurred plus a portion of estimated fees or profits based on the relationship of costs incurred to total estimated costs. Contract costs include all direct material and labor costs and an allocation of allowable indirect costs as defined by each contract, as periodically adjusted to reflect revised agreed upon rates. These rates are subject to audit by the other party. 

Use of Estimates

In accordance with accounting principles generally accepted in the United States of America, management utilizes certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments. Management bases its estimates and judgments on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.

Fair Value of Financial Instruments

The Company's cash, cash equivalents, accounts receivable, short-term investments, accounts payable and debt are shown at cost which approximates fair value due to the short-term nature of these instruments.

Stock-based Compensation

We maintain several stock incentive plans.  The 2005 Employee Stock Purchase Plan provides our employees with the opportunity to purchase common stock through payroll deductions. Employees purchase stock semi-annually at a price that is 85% of the fair market value at certain plan-defined dates. As of September 30, 2008, the plan had not been implemented.

The 2003 Stock Option Plan (the”2003 Plan”) provides for grants of shares of common stock and options to purchase shares of common stock to employees, officers, directors and consultants.   Under the 2003 Plan, an ISO grant is granted at the market value of our common stock at the date of the grant and a non-ISO is granted at a price not to be less than 85% of the market value of the common stock.  These options have a term of up to 10 years and vest over a schedule determined by the Board of Directors, generally over a five year period.  The amended 2003 Plan provides for an annual increase of 3% of the diluted shares outstanding on January 1 of each year for a period of 9 years which commenced January 1, 2005.

The Board of Directors authorized the establishment of the 2008 Incentive Stock Plan with 2,000,000 options available for grant.  The 2008 Incentive Stock Plan is intended to provide long-term performance incentives to directors, executives, selected employees and consultants and reward them for making major contributions to the success and well being of the Company.  As of September 30, 2008, no options have been issued from this plan.
 
18


The Company accounts for its stock based compensation in accordance with the provisions of SFAS No. 123R, “Share-Based Payment”, which requires the Company to recognize expense related to the fair value of the Company’s share-based compensation issued to employees and directors. SFAS 123R requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s condensed consolidated statement of operations. The Company uses the straight-line method for recognizing compensation expense. An estimate for forfeitures is included in compensation expense for awards under SFAS 123R.  See Note 9 to the Condensed Consolidated Financial Statements for a further discussion on stock-based compensation.

NEW ACCOUNTING PRONOUNCEMENTS

See Note 2 of the Condensed Consolidated Financial Statements in Item 1 for a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects on results of operations and financial condition.

RESULTS OF OPERATIONS

THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 2008 COMPARED TO THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 2007

Revenues  
 
Revenues for the three and nine months ended September 30, 2008 were approximately $5.2 million and $13.5 million, respectively, as compared to approximately $5.1 million and $12.9 million for the three and nine months ended September 30, 2007, respectively, an increase of approximately 2% and 5%, respectively.  There was relatively no change in revenues for the three month period as compared to the same period of the prior year.  The higher revenues of $0.6 million for the nine month period as compared to the same period in the prior year was due to an increase in the contract revenues of $1.4 million as a result of additional contracts the Company has obtained offset by a slight decrease in product revenue of $0.8 million.  The decrease in the product revenue was due to a production issue the Company experienced in the first quarter of 2008 which resulted in a shortage of displays.  The Company has rectified the production issue and has seen improvement in its production volume and yield.

Cost of Goods Sold

Cost of goods sold includes direct and indirect costs associated with production.  Cost of goods sold for the three and nine months ended September 30, 2008 were approximately $2.8 million and $8.1 million, respectively, as compared to approximately $3.1 million and $9.1 million, respectively, for the three and nine months ended September 30, 2007.  For the three and nine month periods as compared to the same periods of the prior year there was a decrease of approximately $0.3 million and $1.0 million, respectively. The gross margin for the three and nine months ended September 30, 2008 was approximately $2.4 million and $5.4 million, respectively, as compared to approximately $2.0 million and $3.8 million, respectively, for the three and nine months ended September 30, 2007. As a percentage of revenue this translates to a gross margin for the three and nine months ended September 30, 2008 of 46% and 40%, respectively, as compared to 40% and 29%, respectively, for the three and nine months ended September 30, 2007.  The increase in the gross margin was attributed to fuller utilization of our fixed production overhead due to higher unit production volume, improved yields, and a decrease in the third party rebillable R&D costs.

Operating Expenses

Research and Development.  Research and development expenses include salaries, development materials and other costs specifically allocated to the development of new microdisplay products, OLED materials and subsystems.  Research and development expenses for the three and nine months ended September 30, 2008 were approximately $0.3 million and $1.6 million, respectively, as compared to $0.6 million and $2.3 million for the three and nine months ended September 30, 2007, a decrease of approximately $0.3 million and $0.7 million, respectively.  The decrease was due to the re-deployment of research and development personnel to production contract services which are included in cost of goods sold.

Selling, General and Administrative.  Selling, general and administrative expenses consist principally of salaries, fees for professional services including legal fees, as well as other marketing and administrative expenses.  Selling, general and administrative expenses for the three and nine months ended September 30, 2008 were approximately $1.3 million and $4.8 million, respectively, as compared to approximately $1.4 million and $5.2 million for the three and nine months ended September 30, 2007, a decrease of $0.1 million and $0.4 million, respectively. The decrease of approximately $0.1 million for the three months ended September 30, 2008 was primarily related to a decrease in professional services offset by an increase in the reserve for allowance for bad debts.  The decrease of approximately $0.4 million for the nine months ended September 30, 2008 was primarily related to decreases in personnel costs and professional services offset by an increase in reserve for allowance for bad debts.
 
19


Other Income (Expense), net. Other income (expense), net consists primarily of interest income earned on investments, interest expense related to the secured debt, gain from the change in the derivative liability, and income from the licensing of intangible assets.

For the three and nine months ended September 30, 2008, interest income was approximately $2 thousand and $6 thousand as compared to approximately $9 thousand and $32 thousand for the three and nine months ended September 30, 2007.   The decrease in interest income was primarily a result of lower interest rates on investments.

For the three and nine months ended September 30, 2008, interest expense was approximately $0.5 million and $1.7 million, respectively, as compared to approximately $0.6 million and $2.8 million, respectively, for the three and nine months ended September 30, 2007.   The breakdown of the interest expense for the three and nine month period in 2008 is as follows:  interest expense associated with debt of approximately $178 thousand and $501 thousand, respectively; the amortization of the deferred costs and waiver fees associated with the debt of approximately $331 thousand and $1.2 million, respectively; and the amortization of the debt discount associated with the debt of approximately $0 and $25 thousand, respectively.  The breakdown of the interest expense for the three and nine month period in 2007 is as follows:  interest expense associated with debt of approximately $195 and $652 thousand, respectively; the amortization of the deferred costs associated with the notes payable of approximately $0 and $265 thousand, respectively; and the amortization of the debt discount of approximately $397 thousand and $1.96 million, respectively.

The gain from the change in the derivative liability was $0 for the three and nine months ended September 30, 2008 as compared to approximately $1.5 million and $0.9 million, respectively, for the three and nine months ended September 30, 2007 related to an extinguishment of debt.

Other income, net (excluding interest income), for the three and nine months ended September 30, 2008 was approximately $82 thousand and $288 thousand, respectively,  as compared to approximately $172 thousand and $762 thousand, respectively, for the three and nine months ended September 30, 2007.  Other income, net (excluding interest income)  for the three and nine months ended September 30, 2008 consists of approximately $18 thousand of income from equipment salvage; approximately $142 thousand and $396 thousand, respectively, of  income from the licensing of intangible assets; and is offset by approximately $60 thousand and $126 thousand, respectively, of expense from registration payment arrangements.  See Note 12:  Commitments and Contingencies – Royalty Payments for additional information on the income from licensing of intangible assets.

Liquidity and Capital Resources

As of September 30, 2008, we had approximately $1.4 million of cash and investments as compared to $0.8 million as of December 31, 2007.  The change in cash and investments was primarily due to cash provided by financing activities of $2.7 million offset by cash used for operating activities and investing activities of $2.1 million.

Cash flow used in operating activities during the nine months ended September 30, 2008 was approximately $1.9 million primarily attributable to our net loss of approximately $2.4 million and an increase in accounts receivable of $1.9 million offset by non-cash expenses of $2.5 million. During the nine months ended September 30, 2007, operating activities used cash of approximately $1.7 million attributable to our net loss of approximately $17.3 million and primarily offset by non-cash expenses of $16.1 million.

Cash used in investing activities during the nine months ended September 30, 2008 was approximately $236 thousand used for equipment purchases.  During the nine months ended September 30, 2007, the net cash provided by investing activities was approximately $24 thousand.   There was approximately $33 thousand provided from maturing investments offset by approximately $9 thousand used for equipment purchase.

Cash provided by financing activities during the nine months ended September 30, 2008 was approximately $2.7 million and was comprised of approximately $1.6 million from the sale of common stock, approximately $1.8 million from the line of credit, net of debt financing costs and offset by payments on debt of approximately $0.7 million.  The cash provided by financing activities during the nine months ended September 30, 2007 was approximately $1.0 million and was comprised of proceeds from exercise of warrants of $3 thousand, proceeds from debt of approximately $1.1 million, net of debt financing costs and offset by payments against debt of approximately $48 thousand.
 
20


Our condensed consolidated financial statements as of September 30, 2008 have been prepared under the assumption that we will continue as a going concern. Our independent registered public accounting firm had issued a report dated April 9, 2008 that included an explanatory paragraph expressing substantial doubt in our ability to continue as a going concern. Our ability to continue as a going concern. Our ability to generate a profit which is likely dependent upon our ability to obtain additional equity or debt financing, attain further operating efficiencies and, ultimately, to achieve profitable operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

We anticipate our business will experience revenue growth during the year ending December 31, 2008. This trend may result in higher accounts receivable levels and may require increased production and/or higher inventory levels.   In addition, in December 2008, we will be obligated to repay approximately $6.0 million to the note holders.  If the funds are not available, we will negotiate with the note holders to defer the payment but no assurances can be made that they will agree to this. We anticipate that our cash requirements to fund these requirements as well as other operating or investing cash requirements over the next twelve months will be greater than our current cash on hand.  We anticipate that we will still require additional funds over the next twelve months.  We do not currently have commitments for these funds and no assurance can be given that additional financing will be available, or if available, will be on acceptable terms.

The Company’s ability to obtain additional funding is impacted by its present indebtedness.  The Company’s notes payable have covenants which the Company currently is in compliance with and the covenants contain certain restrictive components that materially limit our ability to raise additional secured debt which is presently limited to a maximum of $3.0 million. The Company has a line of credit with a maximum of $3.0 million which is secured by accounts receivable and inventory which effectively eliminates any additional secured indebtedness under the note covenants.   In addition, pursuant to the notes payable agreement, the Company cannot enter into a consolidation, merger, or acquisition under certain conditions without consent of the note holders.  The Company may raise additional unsecured debt under the note covenants given certain restrictions.  In addition, the notes payable allow for additional equity financing.

If we are unable to obtain sufficient funds during the next twelve months, we may further reduce the size of our organization and may be forced to reduce and/or curtail our production and operations, all of which could have a material adverse impact on our business prospects. The Company is continually reviewing its cost structures for cost efficiencies and is taking measures to reduce non-production costs.

In 2007, we retained CIBC World Markets Corporation and Larkspur Capital Corporation to assist us in investigating and evaluating various strategic alternatives, ranging from investment to acquisition.
 
Off-Balance Sheet Arrangements

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, results of operations, liquidity or capital expenditures.

ITEM 3.  Quantitative and Qualitative Disclosures About Market Risk

Not Applicable.

ITEM 4T.  Controls and Procedures

(a)  Evaluation of Disclosure Controls and Procedures. Based on an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended) required by paragraph (b) of Rule 13a-15 or Rule 15d-15, as of the end of the period covered by this Report, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms. Our Chief Executive Officer and Chief Financial Officer also concluded that, as of the end of the period covered by this Report, there were material weaknesses in both the design and effectiveness of our internal control over financial reporting.  Management has assessed these deficiencies and has determined that there were four general categories of material weaknesses in eMagin’s internal control over financial reporting.  As a result of our assessment that material weaknesses in our internal control over financial reporting existed as of September 30, 2008, management has concluded that our internal control over financial reporting was not effective as of September 30, 2008.  A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
 
21


In management’s opinion, our assessment as of September 30, 2008 regarding the existence of material weaknesses in our internal control over financial reporting relates to (1) the absence of adequate staffing, proper role descriptions, inadequate training and excessive employee turnover, (2) the lack of controls or ineffectively designed controls, (3) the failure in design and operating effectiveness of information technology controls over financial reporting, and (4) failures in operating control effectiveness identified during the testing of the internal control over financial reporting.  Management and our audit committee have assigned a high priority to the short-term and long-term improvement of our internal control over financial reporting.

The material weaknesses we have identified include:

Deficiencies pertaining to a lack of human resources within our finance and accounting functions.  During the latter part of 2007 we experienced significant turnover of personnel in our finance and accounting department, including the positions of Chief Financial Officer and Staff Accountant.  The reduced staffing resulted in instances of altered responsibilities and improper role definition leading to lapses in proper segregation of duties.  The lack of appropriately skilled personnel and less effective monitoring activities related to employee turnover could result in material misstatements to financial statements not being detected in a timely manner.

Deficiencies pertaining to the lack of controls or ineffectively designed controls.  Our control design analysis and process walk-throughs disclosed a number of instances where review approvals were undocumented, where established policies and procedures were not defined, and controls were not in place.

Deficiencies related to information technology control design and operating effectiveness weaknesses.  This material weakness resulted from the absence of key formalized information technology policies and procedures and could result in (1) unauthorized system access, (2) application changes being implemented without adequate reliability testing, (3) inconsistent investigation of system errors and the absence of timely or properly considered remedial actions, and (4) over reliance on spreadsheet applications without quality control assurances.  These factors could lead to material errors and misstatements to financial statements occurring without timely detection.

Deficiencies related to failures in operating effectiveness of the internal control over financial reporting.  Certain internal control procedures were developed during the latter part of 2007.  When testing occurred to confirm the effectiveness of the internal control over financial reporting, controls were not operating effectively.

(b)  Changes in Internal Controls.  During the quarter ended September 30, 2008, there were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


 
22

 

PART II - OTHER INFORMATION

ITEM 1.  Legal Proceedings
 
Other than the legal proceeding pending against the Company as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2007, through September 30, 2008, the Company is not a party to any legal proceedings and there have been no material developments in any legal proceedings reported in such Annual Report.

ITEM 1A.  Risk Factors

In addition to other information set forth in this Report, you should carefully consider the risk factors previously disclosed in “Item 1A to Part 1” of our Annual Report on Form 10-KSB for the year ended December 31, 2007.  There were no material changes from the risk factors during the three and nine months ended September 30, 2008.

ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

On August 26, 2008, the Company and Moriah Capital, L.P. (“Moriah”) entered into Amendment No. 3 to the Loan and Security Agreement dated as of August 20, 2008 (the “Amendment No. 3”). Pursuant to Amendment No. 3, the Company issued Moriah a warrant, which terminates on August 7, 2013, to purchase up to 370,000 shares of the Company’s common stock at an exercise price of $1.30 per share.

Pursuant to Amendment No. 3, the Company and Moriah entered into an Amended and Restated Securities Issuance agreement (the “Amended and Restated Securities Issuance Agreement”).  Pursuant to the Amended and Restated Securities Agreement, the Company is issued Moriah 485,000 shares of its Common Stock.
 
On August 19, 2008, the Holders of the Amended Notes and the Investors in the Purchase Agreement consented to the Company’s execution of the Amended Note, Amendment No. 3, Amended and Restated Securities Issuance Agreement, and the Amended Registration Rights Agreement.  In consideration for the consent, a total of 144,000 shares of common stock were issued to the Holders and Investors based on individual participation in the Amended Notes and Securities Purchase Agreement on September 4, 2008.

We claim an exemption from the registration requirements of the Securities  Act of 1933, amended (the "Act") for the private placement of the above-referenced securities pursuant to Section 4(2) of the Act since, among other things, these transactions did not involve a public offering and we took appropriate measures to restrict the transfer of the securities.

ITEM 3.  Defaults Upon Senior Securities

None.

ITEM 4.  Submission of Matters to a Vote of Security Holders

None.

ITEM 5.  Other Information

None.
 
23


ITEM 6.  Exhibits

EXHIBIT                      
NUMBER                                DESCRIPTION

4.1
Form of Common Stock Purchase Warrant, dated August 7, 2008 (2)

4.2
Form of Amended and Restated Secured Revolving Loan Note, dated August 20, 2008 (2)

10.1
Amendment No. 3 to Loan and Security Agreement, dated as of August 20, 2008 to the Loan and Security Agreement dated August 7, 2007 (2)

10.2
Warrant Issuance Agreement No. 2, dated August 20, 2008 (2)

10.3
Amended and Restated Securities Issuance Agreement, dated as of August 20, 2008 (2)

10.4
Amendment, dated August 20, 2008, to Registration Rights Agreement, dated as of August 7, 2007 (2)
   
31.1  Certification by Chief Executive Officer pursuant to Sarbanes Oxley Section 302 (1)  
   
31.2   Certification by Chief Financial Officer pursuant to Sarbanes Oxley Section 302 (1)   
   
32.1     Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350 (1)
     
32.2 Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (1)
(1)    Filed herewith.  
(2)
Incorporated by reference to the Current Report on Form 8-K, as filed by the Company with the SEC on August 26, 2008.

 
24

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this 13th day of November 14, 2008.
 
 
  eMAGIN CORPORATION  
       
 
By:
/s/ Andrew G. Sculley  
    Andrew G. Sculley  
    Chief Executive Officer  
    Principal Executive Officer  
 
       
 
By:
/s/ Paul Campbell  
    Paul Campbell  
    Interim Chief Financial Officer  
   
Principal Accounting and Financial Officer
 
 
 
 
 
 
 
25